SCAPHOID INJURY

SCAPHOID INJURY

Scaphoid fracture is the most common type of bone fracture in the carpus (ie, wrist).

 

Frequently, however, the diagnosis of this scaphoid injury is delayed; a delay in the diagnosis and treatment of a scaphoid fracture may alter the prognosis for union, increase the risk of avascular necrosis, and dramatically increase the long-term likelihood of arthritis.

PATHOPHYSIOLOGY

ANATOMIC CONSIDERATIONS

The carpus contains 8 small bones, which are arranged in 2 rows, proximal and distal. The proximal bones, from the radial to the medial side, are the scaphoid, lunate, triquetrum, and pisiform.

Only the scaphoid and lunate articulate with the radius; thus, these 2 bones transmit the entire force of a fall on the hand to the forearm. The distal bones are, starting from the radial side, the trapezium, trapezoid, capitate, and hamate.

BLOOD SUPPLY

Anatomically, the scaphoid may be divided into proximal, middle (termed the waist), and distal thirds. Most of the blood supply to the scaphoid enters distally.

The proximal part of the scaphoid has no blood vessels entering it, depending instead on vessels that pierce the midportion. Fractures of the proximal third of the scaphoid account for 20% of scaphoid fractures, those of the middle portion account for 60%, and fractures of the distal part make up the remaining 20%.

Diminished blood flow to the proximal pole is noted in about one third of fractures at the waist level. This reduced blood supply may result in avascular necrosis of the proximal pole of the scaphoid.

Almost 100% of proximal pole fractures result in aseptic necrosis. Displaced scaphoid fractures have a nonunion rate of 55-90%.

FALL ONTO OUTSTRETCHED HAND

The usual mechanism of injury is a fall onto the outstretched hand (FOOSH) that results in forceful dorsiflexion and impaction of the scaphoid against the dorsal rim of the radius.

This mechanism explains why snuffbox tenderness is so common, even in the absence of a scaphoid fracture.

 

Conventional medical wisdom dictates that snuffbox tenderness should be equated with a scaphoid fracture unless radiographs prove otherwise.

If initial radiographs do not show fracture, follow-up radiographs should be obtained in 7-14 days, because the fracture line may be more visible after some resorption.

FREQUENCY

Scaphoid fracture has been reported in people aged 10-70 years, although it is most common in young adult men following a fall, athletic injury, or motor vehicle accident.

MORTALITY/MORBIDITY

The scaphoid has no ligamentous or tendinous attachments, but joint compressive forces, trapezial-scaphoid shear stress, and capitolunate rotation moments exert control on the scaphoid.

Therefore, scaphoid fractures have a high incidence of nonunion (8-10%), frequent malunion, and late sequelae of carpal instability and posttraumatic arthritis.

SEX

Scaphoid injuries are more common in men than in women.

AGE

Scaphoid fracture is uncommon in children because the physis of the distal radius usually fails first, resulting in Salter type I or II fractures of the distal radius.

Similarly, in elderly patients, the distal radial metaphysis usually fails before the scaphoid can fracture.

CLINICAL

HISTORY

Scaphoid fracture can occur through 2 different mechanisms: a compression injury or a hyperextension (ie, bending) injury.

PHYSICAL

The patient with a scaphoid fracture often presents complaining of wrist pain and may be diagnosed as having a sprain of the wrist. In sports-related injuries, it is not uncommon for a fractured scaphoid to go unnoticed.

Pain and tenderness are often on the radial side of the wrist. Pain often is exacerbated with wrist motion.

The importance of increasing the number of clinical tests for this injury is vital; one study found that emergency department residents had difficulty naming diagnostic maneuvers beyond "snuffbox tenderness."

SPECIAL PROVOCATION MANEUVERS

CAUSES

Scaphoid fractures usually are an injury of young men and women, occurring after a fall, athletic injury, or motor vehicle accident.

DIAGNOSIS

LABORATORY STUDIES

IMAGING STUDIES

OTHER TESTS

TREATMENT

PHYSICAL THERAPY

General principles for the rehabilitation of wrist injuries, including the rehabilitation of scaphoid fractures, include the following:

v  All of these injuries require some form of rehabilitation. Specific limitations apply to rehabilitation. Pain is one limiting factor, because it dictates the duration of immobilization and limits exercise designed to mobilize and strengthen the wrist.

v  Edema of the injured wrist is present to some degree and may involve the hand or entire upper extremity. Functional disuse in itself results in edema. The most important preventive measures are elevation and active motion of the uninjured joints. Modalities (eg, Jobst intermittent compression units, massage) may be used later for chronic edema associated with traumatic wrist injuries.

v  The wrist is always stiff after immobilization for more than a few weeks. Mobilization cannot be started until the injured tissue has healed enough to provide some degree of stability. Active wrist ROM exercises should be started as soon as the cast is removed. Pronation and supination should not be overlooked.

v  Mobilizing the joint is desirable before the bone and soft tissues have healed completely. Various splints are required to protect and support the wrist in its final stage of healing.

v  The muscles crossing the wrist must be strengthened after the wrist has healed, edema has been controlled, and motion has improved. Functional activities and progressive resistive exercises are employed. The wrist flexors and extensors are contracted actively against maximum resistance through a full arc of motion.

REHABILITATION CONSIDERATIONS IMMEDIATELY FOLLOWING INJURY TO 1 WEEK

REHABILITATION CONSIDERATIONS IN 2 WEEKS

REHABILITATION CONSIDERATIONS IN 4-6 WEEKS

REHABILITATION CONSIDERATIONS IN 8-12 WEEKS

OCCUPATIONAL THERAPY

The patient usually needs retraining in the performance of activities of daily living (ADL).

The occupational therapist provides the patient with compensatory strategies to use when completing ADL tasks.

Either physical or occupational therapy is necessary for regaining strength and ROM of the affected wrist and hand.

COMPLICATIONS

SURGICAL INTERVENTION

OTHER TREATMENT

MEDICATION

Drugs used for pain management include analgesics. The agents used for mild to moderate pain, such as aspirin, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAIDs), are nonopioids.

These agents usually suffice; if they do not, however, the clinician can prescribe opiate agonists, such as codeine or propoxyphene.

ANALGESICS

Effective management of pain is essential to quality patient care. Pain management improves the patient's quality of life, as well as his/her ability to work productively and to participate in self-care and physical therapy activities. 

ACETAMINOPHEN (Tylenol, Panadol, Tempra)

Effective in relieving mild to moderate acute pain; however, acetaminophen has no peripheral anti-inflammatory effects. It may be preferred in elderly patients because of fewer GI and renal side effects.

Adult: 325-650 mg PO q4-6h prn; alternatively, 1000 mg PO tid/qid; not to exceed 4 g/d; daily dose not to exceed 6 extended-release tab

Pediatric: 10-15 mg/kg PO or PR q4-6h; not to exceed 5 doses in 24 h

Extended-release dose not established for this population

Pregnancy

A - Fetal risk not revealed in controlled studies in humans

Precautions

Hepatotoxicity possible in chronic alcoholics following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; APAP is contained in many OTC products and combined use with these products may result in cumulative APAP doses exceeding recommended maximum dose 

TRAMADOL (Ultram)

Synthetic analog of codeine; however, tramadol has a lower affinity for opioid receptors than does codeine. It has less potential for abuse or respiratory depression than do other opiate agonists, but both may occur.

Tramadol is equivalent in analgesic relief to codeine, but it is less potent than are acetaminophen-codeine and acetaminophen-hydrocodone combinations. A lack of significant cardiac effects and no association with peptic ulcer disease make tramadol an alternative in patients who may not tolerate NSAIDs.

Adult: 50-100 mg PO q4-6h; not to exceed 400 mg/d

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Can cause dizziness, nausea, constipation, sweating, pruritus; additive sedation with alcohol and TCAs; abrupt discontinuation can precipitate opioid withdrawal symptoms; adjust dose in liver disease, myxedema, hypothyroidism, hypoadrenalism; pregnancy, breastfeeding; seizure; development of tolerance or dependency with extended use 

PROPOXYPHENE AND ACETAMINOPHEN (Darvocet N-100)

Used to treat moderate to severe pain. The combination produces additive analgesia compared with the same doses of either agent alone; however, dosage escalation of this combination is limited by the side effects of propoxyphene and by the toxicity and ceiling effect of acetaminophen.

Adult: 1 tab PO q4-6h prn; not to exceed propoxyphene 600 mg/d and acetaminophen 4000 mg/d (6 tab)

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Caution in patients dependent on opiates, substitution may result in acute opiate withdrawal symptoms; caution in severe renal or hepatic dysfunction 

ACETAMINOPHEN AND CODEINE (Tylenol #3)

Used to treat moderate to severe pain. Tylenol #3 produces additive analgesia compared with the same doses of either agent alone. Dosage escalation of this combination is limited by the ceiling effect of acetaminophen.

Adult: 30-60 mg based on codeine content PO q4-6h or 1-2 tab q4h; not to exceed 12 tab/d

Pediatric: 1-1.5 mg/kg/d codeine PO q4-6h prn; not to exceed 75 mg/kg/d of acetaminophen 

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Caution in patients with COPD or decreased pulmonary reserve; renal and hepatic dysfunction; abrupt discontinuation can result in withdrawal symptoms; patients with asthma who also have salicylate hypersensitivity

CYCLOOXYGENASE-2 (COX-2) INHIBITORS

Although increased cost can be a negative factor, the incidence of costly and potentially fatal GI bleeds is clearly less with COX-2 inhibitors than with traditional NSAIDs. Ongoing analysis of cost avoidance of GI bleeds will further define the populations that will find COX-2 inhibitors the most beneficial. 

CELECOXIB (Celebrex)

Inhibits primarily COX-2. COX-2 is considered an inducible isoenzyme, induced during pain and inflammatory stimuli. Inhibition of COX-1 may contribute to NSAID GI toxicity. At therapeutic concentrations, COX-1 isoenzyme is not inhibited; thus, GI toxicity may be decreased. Seek the lowest dose of celecoxib for each patient.

Adult: 200 mg PO qd or 100 mg PO bid

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

May cause fluid retention and peripheral edema; caution in compromised cardiac function, hypertension, conditions predisposing to fluid retention; severe heart failure and hyponatremia, because may deteriorate circulatory hemodynamics; NSAIDs may mask usual signs of infection; caution in the presence of existing controlled infections; evaluate symptoms and signs suggesting liver dysfunction, or in abnormal liver lab results

NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)

Have analgesic, anti-inflammatory, and antipyretic activities. Their mechanism of action is not known, but they may inhibit COX activity and prostaglandin synthesis.

Other mechanisms may exist as well, such as the inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell-membrane functions. 

KETOPROFEN (Orudis, Actron, Oruvail)

For relief of mild to moderate pain and inflammation.

Small dosages initially are indicated in small and elderly patients and in those with renal or liver disease.

Doses over 75 mg do not increase the therapeutic effects. Administer high doses with caution and closely observe the patient for a response.

Adult: 25-50 mg PO q6-8h prn; not to exceed 300 mg/d

Pediatric:

<3 months: Not established

3 months to 12 years: 0.1-1 mg/kg PO q6-8h

>12 years: Administer as in adults

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy 

NAPROXEN (Naprelan, Anaprox, Naprosyn)

For relief of mild to moderate pain; naproxen inhibits inflammatory reactions and pain by decreasing the activity of COX, which results in a decrease in prostaglandin synthesis.

Adult: 500 mg PO followed by 250 mg q6-8h; not to exceed 1.25 g/d

Pediatric:

<2 years: Not established

>2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug 

IBUPROFEN (Motrin, Advil, Nuprin, Rufin)

Oral NSAID with analgesic and antipyretic properties. Ibuprofen is useful for the alleviation of mild to moderate pain.

Adult: 400-800 mg PO tid/qid; not to exceed 3200 mg/d; use lowest effective dose

Pediatric: 30-40 mg/kg PO tid/qid in divided doses; not to exceed 50 mg/kg/d.